119 related articles for article (PubMed ID: 16868463)
1. The recognition and treatment of amyloidosis in the critical care patient.
McGowan N
Dimens Crit Care Nurs; 2006; 25(4):161-4. PubMed ID: 16868463
[TBL] [Abstract][Full Text] [Related]
2. What's wrong with this patient? Primary systemic amyloidosis.
McGowan N
RN; 2006 Nov; 69(11):37-40. PubMed ID: 17128867
[No Abstract] [Full Text] [Related]
3. Managing the patient with amyloidosis.
Cannon JD; Pullen RL; Rushing JD
Dermatol Nurs; 2004 Jun; 16(3):225-30, 234; quiz 235. PubMed ID: 15307623
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
[TBL] [Abstract][Full Text] [Related]
5. Guidelines on the diagnosis and management of AL amyloidosis.
;
Br J Haematol; 2004 Jun; 125(6):681-700. PubMed ID: 15180858
[No Abstract] [Full Text] [Related]
6. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
[TBL] [Abstract][Full Text] [Related]
7. Therapy and management of systemic AL (primary) amyloidosis.
Palladini G; Perfetti V; Merlini G
Swiss Med Wkly; 2006 Nov; 136(45-46):715-20. PubMed ID: 17183435
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of AL amyloidosis, current data].
Jaccard A
Rev Med Interne; 2006 Nov; 27(11):809-12. PubMed ID: 16934914
[No Abstract] [Full Text] [Related]
9. Recent advances in the management of AL Amyloidosis.
Kastritis E; Dimopoulos MA
Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
[TBL] [Abstract][Full Text] [Related]
10. [Current treatment of AL amyloidosis].
Kovacsovics T
Rev Med Suisse Romande; 2000 Oct; 120(10):771-5. PubMed ID: 11109905
[TBL] [Abstract][Full Text] [Related]
11. Understanding the basics of primary systemic amyloidosis.
Schumacher DL
J Contin Educ Nurs; 2004; 35(1):15-6. PubMed ID: 14870905
[No Abstract] [Full Text] [Related]
12. [Light chain amyloidosis--clinical symptoms, update diagnosis, and treatment].
Charliński G; Jurczyszyn A; Wiktor-Jedrzejczak W
Przegl Lek; 2014; 71(2):102-9. PubMed ID: 25016786
[TBL] [Abstract][Full Text] [Related]
13. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.
Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F
Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836
[TBL] [Abstract][Full Text] [Related]
14. Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study.
Scott EC; Heitner SB; Dibb W; Meyers G; Smith SD; Abar F; Kovacsovics T; Perez-Avraham G; Stentz A; Frires R; Dibb J; Maziarz RT
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):424-430.e1. PubMed ID: 24650974
[TBL] [Abstract][Full Text] [Related]
15. Primary amyloidosis of the kidney.
Shafique S; Wetmore J; Almehmi A
W V Med J; 2010; 106(1):22-4. PubMed ID: 20088306
[TBL] [Abstract][Full Text] [Related]
16. Waxy indurated plaques on the eyelids.
Aleshin MA; Custis TD; Gharavi NM; Goh C; Young LC
Cutis; 2015 Feb; 95(2):E24-7. PubMed ID: 25750974
[No Abstract] [Full Text] [Related]
17. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic syndrome secondary to amyloidosis.
Kneipp S; Himmelstein SB
Nurse Pract; 2000 Jun; 25(6 Pt 1):78, 81, 85-6 passim. PubMed ID: 10884998
[TBL] [Abstract][Full Text] [Related]
19. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.
Sanchorawala V; Seldin DC
Amyloid; 2007 Dec; 14(4):261-9. PubMed ID: 17968685
[TBL] [Abstract][Full Text] [Related]
20. Managing systemic light-chain amyloidosis.
Comenzo RL
J Natl Compr Canc Netw; 2007 Feb; 5(2):179-87. PubMed ID: 17335687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
